Gene: DENND4A
Official Full Name: DENN domain containing 4Aprovided by HGNC
Gene Summary: This gene encodes a DENN domain-containing protein that may function as a guanine nucleotide exchange factor that specifically activates ras-related protein Rab-10. This protein also contains a interferon stimulated response element-binding domain and may be involved in regulating the v-myc avian myelocytomatosis viral (MYC) oncogene. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 8. [provided by RefSeq, Mar 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32067 | DENND4A Knockout cell line (HeLa) | Human | DENND4A | 1:3~1:6 | Negative | Online Inquiry |
KO32068 | DENND4A Knockout cell line (HCT 116) | Human | DENND4A | 1:2~1:4 | Negative | Online Inquiry |
KO32069 | DENND4A Knockout cell line (HEK293) | Human | DENND4A | 1:3~1:6 | Negative | Online Inquiry |
KO32070 | DENND4A Knockout cell line (A549) | Human | DENND4A | 1:3~1:4 | Negative | Online Inquiry |
DENND4A Gene Knockout Cell Lines are advanced biological tools specifically engineered to silence the expression of the DENND4A gene, which plays a crucial role in various cellular signaling pathways and protein transport mechanisms. These knockout cell lines provide researchers with a robust system to study the functional implications of DENND4A deficiency in a controlled environment, allowing for in-depth exploration of its role in processes such as endocytosis, signal transduction, and cellular homeostasis.
The key function of DENND4A Gene Knockout Cell Lines lies in their ability to eliminate the expression of the DENND4A protein, which can influence the activity of Ras and Rho small GTPase signaling pathways. By utilizing CRISPR-Cas9 technology for gene editing, these cell lines assure precise and efficient knockout of the target gene, establishing a platform for investigating the downstream effects of its absence. This targeted approach enables scientists to examine cellular responses, adaptability, and pathophysiology under conditions mimicking genetic disorders or diseases where DENND4A is implicated.
In research and clinical contexts, the DENND4A Gene Knockout Cell Lines serve as a valuable tool for elucidating disease mechanisms, particularly in cancer and neurodegenerative diseases. Their application extends to drug discovery, where understanding the role of DENND4A can lead to the identification of novel therapeutic targets or biomarkers. Compared to alternative models, such as siRNA knockdowns or chemical inhibitors, the permanence of the knockout offers unparalleled consistency and reliability for long-term studies.
The key advantages of these cell lines include high specificity, reproducibility, and ease of use, making them indispensable for laboratories focused on the functional genomics of cellular signaling. By investing in the DENND4A Gene Knockout Cell Lines, researchers can significantly accelerate their discovery processes while minimizing variability.
Our company is dedicated to providing high-quality biological products backed by expertise in genetic engineering and cell line development, ensuring that researchers and clinicians have access to the best tools available to advance their investigative efforts in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.